Type strain

A type strain is a living reference lineage designated as the nomenclatural type of a species or subspecies in prokaryotic nomenclature. It consists of cultures descended from the designated strain, rather than one uniquely irreplaceable physical vial. The Code expects close agreement with the original description.^[ref]

This role supports comparisons between biological observations and a named reference. Culture collections preserve and identify such material; their accession identifiers can supply different labels for the same underlying type strain.^[ref]

Consider a constructed database example. Collection A labels the designated lineage A-101, while collection B labels a documented descendant B-202. Counting the two accessions as two independent species would confuse storage records with biological classification. The essential record is the documented relationship between the materials, the designated lineage and the name.

A type strain supplies a reference, not a guarantee that every other bacterial strain in the same species has identical phenotypes. It is also a living lineage whose measured properties require appropriate characterization. A comparison should state the actual material and conditions tested, so that a discrepancy can be investigated rather than silently attributed to an entire species.

A culture collection maintains documented living cultures of microorganisms for later study and comparison. Its scientific resource consists of both the biological material and the records connecting that material to its origin, identity and measured properties. Microbial culture preservation maintains recoverable material, while microbial culture authentication investigates whether it is the intended strain.^[ref]

These functions support reproducibility. A reported effect can be tested on a documented reference rather than on an organism identified only by an informal description. A type strain has an additional nomenclatural role, but a culture collection can also maintain other research strains.^[ref]

Identity and viability are distinct endpoints. In an invented inspection of twenty stored cultures, suppose eighteen yield viable growth and seventeen of those eighteen match the intended identity. The observed recovery fraction is $18/20=90\%$, the matching fraction among recovered cultures is $17/18\approx 94.4\%$, and the fraction passing both checks is $17/20=85\%$. Reporting just one percentage would conceal which question was tested. These counts illustrate assessment, rather than collection performance data.

ATCC's own account combines morphological, biochemical and genotypic characterization when assessing its prokaryotic materials. Such complementary observations test more than whether a tube produces growth.^[ref] A culture collection consequently provides a connection between a named biological reference and material that another laboratory can actually examine.

Microbial culture authentication checks whether cultured material has the identity and relevant properties claimed for it. Within a culture collection, it connects a named strain to observations of the actual material. Tests of phenotype, purity and genotype can supply complementary evidence; growth alone does not identify the organism.^[ref]

ATCC describes comparisons at both the cell and colony level, biochemical characterization and sequence-based identification. Its account also explains that identifying some organisms or confirming a particular feature requires information beyond one commonly used marker.^[ref]

A constructed coverage example makes the limit precise. Suppose a reference and an isolate agree at all one thousand positions examined in a hypothetical million-position genome. That establishes agreement at the tested positions, not at the remaining 999,000. Two preparations could share the tested sequence while differing elsewhere. Conversely, an observed difference needs interpretation in the context of assay quality and what kind of identity the comparison is intended to establish.

Purity is another distinct question. A result identifying the dominant sequence does not by itself exclude a second microorganism that the measurement fails to detect. The reference material, tested features and detection capability should therefore accompany an authentication claim.

The WFCC guidelines emphasize comparing a recovered strain with the originally deposited material and retaining supporting records.^[ref] Authentication supplies evidence about identity; microbial culture preservation maintains the material on which that evidence depends.

Microbial culture preservation maintains recoverable cultures while retaining the biological properties needed for their future use. A successful preservation claim therefore concerns both viability and the identity or relevant characteristics of the recovered strain. It is part of the scientific function of a culture collection.^[ref]

Approaches include microbial cryopreservation and freeze-drying. Their suitability depends on the material. ATCC's account explains that maintaining reference stocks can reduce the changes associated with repeated growth and passage, including changes caused by genetic instability and selection.^[ref]

A toy selection model illustrates why repeated growth and preservation are different objectives. Begin with two variants A and B at equal abundance. Suppose each transfer multiplies their abundance ratio by $1.1$ in favour of A. After ten transfers the ratio is $1.1^{10}\approx 2.594$, making A's fractionBoth variants can remain viable while their proportions change from one half to about $72.2\%$ and $27.8\%$. These invented values illustrate cumulative selection, not observed performance of a preservation method.

Recovery and comparison complete the scientific check. Obtaining growth shows that some material remains viable; confirming the intended genotype or phenotype asks another question. Records of origin, preservation history and characterization connect those observations. Separately maintained duplicates also protect a collection against loss of a single stored resource.^[ref]

A colony-forming unit, abbreviated CFU, is a unit of viable material that produces a distinguishable colony under specified assay conditions. It may begin as one cell or as a clump. Counting colonies therefore measures colony-producing units, rather than automatically counting every living cell in the original sample.^[ref]

A measured concentration also requires an accounting of sample volume and dilution. In a simple plate-count model with $n$ colonies, plated volume $V$ and dilution fraction $d$, the original-sample estimate isIf $V$ is in millilitres, $\hat{C}$ is in CFU per millilitre. The fraction $d$ is the amount of original sample in one volume of the diluted preparation; it is not the reciprocal dilution factor.^[ref]

For an original benign-yeast example, suppose two matched measurements yield50 and70 colonies, each from $0.1\mathrm{mL}$ at $d=10^{-3}$. Pooling the counts and effective volumes givesThis assumes a well-mixed preparation, comparable recovery and distinct countable colonies. It is an arithmetic illustration, not a recommendation for culturing a particular organism.

A culture medium, incubation conditions and recovery state determine which viable units become visible. A zero count in a finite tested volume does not prove that no viable material exists anywhere in the sample. Crowded colonies, clumping and assay inhibition also affect interpretation; the method and its reporting conventions should accompany the result.^[ref]

Microbial cryopreservation preserves viable microorganisms at very low temperature for later recovery. It provides stored starting material for future experiments, reducing repeated propagation and the associated opportunities for contamination or changes in inherited characteristics. Recovery, purity and identity remain separate properties to verify.^[ref]

Freezing can injure a cell even though low temperature greatly slows its activity. Formation of ice removes liquid water from the surrounding solution and concentrates its dissolved substances; intracellular ice can damage cellular structures. Water movement by osmosis links the external changes to cellular dehydration. Microbial cryoprotectants, including glycerol, help protect the material, but preservation performance depends on the particular organism and conditions.^[ref]

A constructed recovery measurement makes the accounting explicit. Suppose equal original-volume equivalents of a benign yeast suspension give $N_0=1000$ colony-forming units before storage and $N_1=700$ after recovery, using the same assay and correcting for any dilution. The estimated recovery fraction isThese are counts of colony-producing units under the assay conditions. Clumps can form single colonies, so the result does not by itself show that exactly seventy percent of individual cells survived. Nor does a high recovery fraction establish unchanged genotype or every original phenotype.

The point of maintaining a preserved reference is reproducibility: separate experiments can begin from material derived from the same stored stock. Microbial cryopreservation retains frozen material, whereas freeze-drying removes water from frozen material. They are different preservation strategies, whose suitability must be established for the material concerned.^[ref]

A microbial cryoprotectant is a substance added to help viable microorganisms withstand freezing and subsequent recovery during microbial cryopreservation. Protection is assessed in the preserved material; the label does not mean that a substance is harmless at every concentration or suitable for every strain.

Freezing changes both the amount of liquid water and the concentration of dissolved substances. Intracellular ice can injure structures, while water movement by osmosis can shrink a cell. ATCC identifies glycerol and dimethyl sulfoxide as common protective agents and stresses that useful formulations depend on the material. Protecting a frozen preparation involves more than simply lowering its nominal temperature.^[ref]

An original comparison measures recovery rather than assuming protection from composition. Split a benign yeast preparation into two matched portions. Suppose each has1000 initial colony-forming units per original-volume equivalent, while recovery gives300 units without a candidate additive and700 with it. The recovered fractions are0.30 and0.70: a difference of0.40, or40 percentage points, and a ratio $700/300\approx 2.33$. These invented measurements would support improved recovery in that comparison, not a universal survival rate.

Equal original-volume equivalents matter because adding a solution also dilutes the cells. A matched nonfrozen comparison can help separate freezing injury from an additive's effect on the growth readout. Recovery of colony-forming units, unchanged genotype and preservation of a chosen phenotype are separate questions.

The practical motivation is to retain a reproducible biological starting point between experiments. A microbial cryoprotectant is one part of that preservation system, alongside the physical freezing history, storage and subsequent authentication.^[ref]